Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
Main Authors: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2013
|
פריטים דומים
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
מאת: Cornelissen, B, et al.
יצא לאור: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
מאת: Cornelissen, B, et al.
יצא לאור: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
מאת: Malcolm, J, et al.
יצא לאור: (2019) -
Radiopharmaceuticals for imaging and therapy.
מאת: Faulkner, S, et al.
יצא לאור: (2011) -
Regulation of Radiopharmaceutical Products
מאת: V. V. Kosenko, et al.
יצא לאור: (2022-12-01)